Diagnosis and Treatment of Diabetic Foot Infections

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Full frame distilled prediction

Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

Candidate categories

none

Consensus categories

none

Domain

Candidate signal: noneConsensus signal: none

Study design

Candidate signal: ObservationalConsensus signal: Observational

Genre

Candidate signal: EmpiricalConsensus signal: Empirical

Teacher disagreement score

0.059

Threshold uncertainty score

0.491

Validation status

machine_predicted_unvalidated · codex-gemma-dda1882f352a

Codex and Gemma teacher scores by category

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Teacher spread

0.330 · how far apart the two teachers sit on this one work

Validation status

score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Abstract

1. Foot infections in patients with diabetes cause substantial morbidity and frequent visits to health care professionals and may lead to amputation of a lower extremity. 2. Diabetic foot infections require attention to local (foot) and systemic (metabolic) issues and coordinated management, preferably by a multidisciplinary foot-care team (A-II) (table 1). The team managing these infections should include, or have ready access to, an infectious diseases specialist or a medical microbiologist (B-II). Infectious Diseases Society of America—United States Public Health Service Grading System for ranking recommendations in clinical guidelines. 3. The major predisposing factor to these infections is foot ulceration, which is usually related to peripheral neuropathy. Peripheral vascular disease and various immunological disturbances play a secondary role. 4. Aerobic gram-positive cocci (especially Staphylococcus aureus) are the predominant pathogens in diabetic foot infections. Patients who have chronic wounds or who have recently received antibiotic therapy may also be infected with gram-negative rods, and those with foot ischemia or gangrene may have obligate anaerobic pathogens. 5. Wound infections must be diagnosed clinically on the basis of local (and occasionally systemic) signs and symptoms of inflammation. Laboratory (including microbiological) investigations are of limited use for diagnosing infection, except in cases of osteomyelitis (B-II). 6. Send appropriately obtained specimens for culture prior to starting empirical antibiotic therapy in all cases of infection, except perhaps those that are mild and previously untreated (B-III). Tissue specimens obtained by biopsy, ulcer curettage, or aspiration are preferable to wound swab specimens (A-I). 7. Imaging studies may help diagnose or better define deep, soft-tissue purulent collections and are usually needed to detect pathological findings in bone. Plain radiography may be adequate in many cases, but MRI (in preference to isotope scanning) is more sensitive and specific, especially for detection of soft-tissue lesions (A-I). 8. Infections should be categorized by their severity on the basis of readily assessable clinical and laboratory features (B-II). Most important among these are the specific tissues involved, the adequacy of arterial perfusion, and the presence of systemic toxicity or metabolic instability. Categorization helps determine the degree of risk to the patient and the limb and, thus, the urgency and venue of management. 9. Available evidence does not support treating clinically uninfected ulcers with antibiotic therapy (D-III). Antibiotic therapy is necessary for virtually all infected wounds, but it is often insufficient without appropriate wound care. 10. Select an empirical antibiotic regimen on the basis of the severity of the infection and the likely etiologic agent(s) (B-II). Therapy aimed solely at aerobic gram-positive cocci may be sufficient for mild-to-moderate infections in patients who have not recently received antibiotic therapy (A-II). Broad-spectrum empirical therapy is not routinely required but is indicated for severe infections, pending culture results and antibiotic susceptibility data (B-III). Take into consideration any recent antibiotic therapy and local antibiotic susceptibility data, especially the prevalence of methicillin-resistant S. aureus (MRSA) or other resistant organisms. Definitive therapy should be based on both the culture results and susceptibility data and the clinical response to the empirical regimen (C-III). 11. There is only limited evidence with which to make informed choices among the various topical, oral, and parenteral antibiotic agents. Virtually all severe and some moderate infections require parenteral therapy, at least initially (C-III). Highly bioavailable oral antibiotics can be used in most mild and in many moderate infections, including some cases of osteomyelitis (A-II). Topical therapy may be used for some mild superficial infections (B-I). 12. Continue antibiotic therapy until there is evidence that the infection has resolved but not necessarily until a wound has healed. Suggestions for the duration of antibiotic therapy are as follows: for mild infections, 1–2 weeks usually suffices, but some require an additional 1–2 weeks; for moderate and severe infections, usually 2–4 weeks is sufficient, depending on the structures involved, the adequacy of debridement, the type of soft-tissue wound cover, and wound vascularity (A-II); and for osteomyelitis, generally at least 4–6 weeks is required, but a shorter duration is sufficient if the entire infected bone is removed, and probably a longer duration is needed if infected bone remains (B-II). 13. If an infection in a clinically stable patient fails to respond to ⩾1 antibiotic courses, consider discontinuing all antimicrobials and, after a few days, obtaining optimal culture specimens (C-III). 14. Seek surgical consultation and, when needed, intervention for infections accompanied by a deep abscess, extensive bone or joint involvement, crepitus, substantial necrosis or gangrene, or necrotizing fasciitis (A-II). Evaluating the limb's arterial supply and revascularizing when indicated are particularly important. Surgeons with experience and interest in the field should be recruited by the foot-care team, if possible. 15. Providing optimal wound care, in addition to appropriate antibiotic treatment of the infection, is crucial for healing (A-I). This includes proper wound cleansing, debridement of any callus and necrotic tissue, and, especially, off-loading of pressure. There is insufficient evidence to recommend use of a specific wound dressing or any type of wound healing agents or products for infected foot wounds. 16. Patients with infected wounds require early and careful follow-up observation to ensure that the selected medical and surgical treatment regimens have been appropriate and effective (B-III). 17. Studies have not adequately defined the role of most adjunctive therapies for diabetic foot infections, but systematic reviews suggest that granulocyte colony-stimulating factors and systemic hyperbaric oxygen therapy may help prevent amputations (B-I). These treatments may be useful for severe infections or for those that have not adequately responded to therapy, despite correcting for all amenable local and systemic adverse factors. 18. Spread of infection to bone (osteitis or osteomyelitis) may be difficult to distinguish from and may but bone is for the of osteomyelitis, for the and for the antibiotic of (B-II). field has is The especially that adequately studies be to and for infection, diagnosing osteomyelitis, optimal antibiotic regimens in various and the role of in treating osteomyelitis of the Foot infections in with diabetes are a and addition to severe for the of and are the most cause of amputations Diabetic foot infections require careful attention and coordinated management, preferably by a multidisciplinary foot-care team (A-II) The team managing these infections should preferably include, or have ready access to, an infectious diseases specialist or a medical microbiologist of diabetic foot infections can the of the for and duration of and the of major limb amputation these infections are This may from a of of and insufficient to the or a of effective multidisciplinary The of is to help the medical and with diabetic foot infections. The of is on managing the diabetic patient with or foot infection, other the of the diabetic foot and diabetic foot The that the of care and the of in some clinical the of some of the and that in all care is usually more difficult to or care and This should a for treating all diabetic patients who have a foot health care be to it better and of of may the and with including those related to antibiotic wound care, surgical and adjunctive it to the of lower in with the may may be by an for foot care, (especially and vascular This is of Infectious Diseases Society of with experience and interest in diabetic foot infections, many of also have experience in guidelines. are from and other their and clinical infectious diseases clinical and of the are also of the on the Diabetic which on and Diabetic Foot Infections in an extensive the the the diabetic foot and and of of and all evidence in a of and and a of that and these as a basis for the which that based on both and of the of or other evidence in most of recommendations are based on and (table to a and to an extensive for those who to the data diabetic foot infection is most defined as any infection in a with diabetes These necrotizing and The most and is the infected diabetic foot This wound results from a of risk factors which are in 2. the with disturbances of and to to or on a foot that the of is tissues are to This wound may to and, by the infection can This of can be or especially in an especially those that may some diabetic and these likely the risk and severity of foot infections factors for foot and Aerobic gram-positive cocci are the predominant that and in the S. aureus and the and but especially are the most pathogens wounds a more including various obligate and, other gram-negative surgical and, especially, or antibiotic therapy may patients to infection with or have previously been from cases are and are with in patients with diabetic foot infections S. aureus has been in the cases of S. aureus a diabetic patient with a foot infection The necrotic or bone may as and to a role infections in patients who have not recently received antimicrobials are often with an aerobic gram-positive chronic infections are often of specimens obtained from patients with infections generally including gram-positive and gram-negative and The role of in a infection is often clinical infection and the pathogens most likely in with with various clinical Diabetic patients may many of foot wounds, any of which can should be diagnosed clinically on the basis of the presence of purulent or at least of the of or and or not all ulcers are infected an infection often to, but is not defined healing of an of diabetic foot infections and the severity of infection as the basis for the appropriate to treatment (B-II). The of osteomyelitis is particularly and and is with to treating a diabetic patient with a foot wound of the infection should at as in and the patient as a the limb or and the infected The is to determine the clinical (table and the (table of the infection, the or of the any of foot to the cause of the wound thus, to any of vascular (especially and the presence of any systemic of the or experience to any of these should appropriate Evaluating the diabetic patient who has an infected of soft-tissue specimens from an infected diabetic foot for The results of the in can be used to determine the severity of the infection and to a (B-II). the of on wound and infection of The has been used for but for the is severe and all infections a is that the issues in a diabetic foot wound are (in which tissues are and the wound is by ischemia or infection (B-II). The on the Diabetic Foot recently a on a diabetic foot ulcer for The are by the infection, and The infection includes of and or and of a systemic response is to be to all it includes a of for uninfected 2–4 are to those in 6. to treating a diabetic patient with a foot if any of the are systemic toxicity and metabolic severe or or infection, substantial necrosis or gangrene, or presence of of or and to care for or of a diabetic foot infected wounds the most important is to patients who require parenteral and empirical antibiotic therapy, and consideration of and surgical have defined these infections as Infections defined as must be from clinically uninfected lesions but are to infections as the a of wounds, some of which can be and limb have used the and with mild and but to with the various that can a The moderate and severe infections has to with the of the foot with the patient to it is This is by the that of patients with a infection not systemic signs or the in as a basis for in and (B-II). antibiotics for uninfected that many uninfected diabetic foot ulcers are a of defined as of that results in and wound healing Available evidence does not support the use of antibiotics for the of clinically uninfected to wound healing or as infection antibiotic use and may cause adverse therapy of uninfected some it is difficult to a chronic wound is as when the foot is has or a has tissue, is with or or when an ulcer fails to healing these cases, a of antibiotic therapy may be appropriate (C-III). the for is the most of treating a diabetic foot infection, and on consideration of both medical and Patients with infections that are severe or by limb ischemia should generally be patients with mild infections and more patients with moderate infections may also may be for or factors are likely to their wound care or to antibiotic the of these most patients with mild or moderate infections can be as (A-II) the to the metabolic of the patient is This may of the and of and and treatment of other patients who require should usually be to the should usually not be for after to the The of may in both the infection and healing the wound the infection may be to an antibiotic of the antibiotic regimen initially the of therapy, the of to be and the specific to and the regimen and the duration of therapy is usually empirical and should be based on the severity of the infection and on any data, as recent culture results or severe infections and for chronic moderate infections, it is to therapy with agents. These should have gram-positive cocci (including in is as as gram-negative and obligate anaerobic (B-III). ensure adequate and therapy should be at least initially (C-III). some suggest empirical therapy for most infections the of many can be with agents with a as those only aerobic gram-positive cocci (A-II) anaerobic are from many severe infections are in mild-to-moderate infections and there is evidence to support the for therapy in most infections (B-III). mild-to-moderate infections in patients without and for an oral with the appropriate is oral therapy is often especially with bioavailable agents (A-II). infected wounds with limited data support the use of therapy in effective in infected diabetic foot lesions is with the of the specific and, especially, the arterial supply to the with diabetes There are few clinical of antibiotic therapy for diabetic foot antibiotic patients with various and soft-tissue infections have some patients with diabetic foot infections. a of clinical that on therapy of diabetic foot infections, or as an of a The of among these the of of regimens The of infection severity and clinical that used in these the to a for the basis of the or of agents to be to Antibiotic agents used in clinical studies of diabetic foot infections. some empirical antibiotic regimens to the clinical severity of the infection, the data not to recommend any specific antibiotic regimen for diabetic foot infections (B-II). These agents are from clinical and experience and are not to be of all agents be depending on various and antibiotic therapy when culture and susceptibility results are (C-III). choices for patients who are not to antibiotic therapy should agents that a or of The regimens in are in of the does not by the of antibiotic agents should be selected to of the and the and the experience of the and should be on the basis of any (especially and other clinical factors. empirical antibiotic based on clinical for diabetic foot infections. to a diabetic patient with a foot infection who is not to of the for infections require surgical that from and of infected and necrotic tissues to of the lower and of soft-tissue or surgical treatment of diabetic foot infections is based on evidence that for antibiotic therapy Seek surgical consultation for or infections, as those with necrotizing gangrene, extensive soft-tissue or evidence of or those in with ischemia (A-II) surgical specialist should also patients who have foot or evidence of a infection, deep or infection in the of appropriate medical care and surgical debridement, including limited or may the for amputation especially in an can cause and patients with infections, it may be appropriate to to the of medical therapy or to determine the necrotic and The must determine the adequacy of the supply to the consider infection among foot to the deep or the and a for soft-tissue secondary or The surgical should the for healing and should to the of the of the foot addition to the must have sufficient and experience to when and to The is important or of the of the the of and infection, and experience with and for the field most the should to the patient until the infection is and the wound is healing (B-III). some cases, amputation is the or only amputation is usually required only when there is extensive necrosis or infection amputation may be for the patient who has has of foot or require or care of the of amputation must into consideration and issues the should to as of the limb as possible. a amputation that results in a more if a is may be a better a foot that is to or to all or of a foot has gangrene, it may be preferable (especially for a patient for is a to the necrotic may also be to in especially on the until to be more removed, there does not to be an of infection If the infected limb to be the patient should be to a with vascular most cases, ischemia is to to the and the to be may be amenable to or vascular Patients with ischemia those with an to of can usually be without a vascular vascular disease of the many have use of in diabetic patients a patient with a infected it is usually preferable to any needed early after the infection 1–2 to in of (and antibiotic therapy the other careful debridement of necrotic infected should not be surgical may require a The wound may require additional attention after the debridement the (table The is to and tissue, wound healing and a of pathogens may limited This can usually be as a or and without especially for a debridement with or is generally preferable to or which are and and may require and There are many products that are as to healing in various but a of these is The infected wound should be in a that and a (B-III). evidence any type of and are important of from a foot wound is crucial to the healing of can the infected but it is important to that and have many of including wound factors and therapy treatment likely has some appropriate for infected wounds, evidence is insufficient to recommend use of any of these for treatment or adjunctive granulocyte colony-stimulating factors have been in diabetic foot infections of these that does not of infection but may the for and suggest that hyperbaric oxygen therapy may be of for treatment of diabetic foot wounds, and a few recent studies have results recent that hyperbaric oxygen therapy the risk of major amputation related to a diabetic foot ulcer (B-I). additional clinical can for and with these and limited be used in the treatment of diabetic foot infections. should be used as a for proper surgical debridement and observation of the response to therapy is and should be for and perhaps initially for (B-III). The of are of local and systemic symptoms and clinical signs of inflammation. including and as the and the are of limited use for is it to and cause for when to antibiotic therapy for a diabetic patient with a foot methicillin-resistant Staphylococcus a patient is ready for or an for the should and 1. Select the antibiotic the culture and susceptibility results and any adverse related to the antibiotic a antibiotic regimen (including the treatment on the basis of the results of or other and the clinical response (C-III). is not necessary to all from S. aureus and or should be but in a infection, and may be important (B-II). If the infection has not responded to the empirical agents with all a clinically stable patient who has ⩾1 of therapy, consider discontinuing antimicrobials for a few and optimal specimens for culture (C-III). 2. the the to ensure that the infection is and that the wound is If is the for surgical evidence antibiotics for the entire that the wound remains should be used for a defined by the of the infection and by the clinical as in (A-II). If clinical evidence of infection the on the with antibiotics and for adverse factors These may the of antibiotic a an deep or of osteomyelitis, or ischemia that is more severe initially and of antibiotic therapy, by clinical 3. the off-loading and wound care the and the the consultation when 4. that and other of the metabolic are adequately with osteomyelitis is perhaps the most difficult and in the of diabetic foot infections among is that the of a of the disease the of studies and there are many but often the presence of osteomyelitis the of surgical including and the required duration of antibiotic therapy osteomyelitis healing of the wound and as a for to consider the osteomyelitis as a of any deep or extensive especially that is chronic or a osteomyelitis when an ulcer does not after at least weeks of appropriate care and ulcer in which bone is or can be with a is likely to be by osteomyelitis patients with a infection, results of a may be as sufficient for but the of have not been foot in a patient with a of foot ulceration, a a or an or should also of osteomyelitis (B-II). bone an ulcer should be to osteomyelitis a diabetic patient who has osteomyelitis of the and or be or preferably after antibiotic therapy has been for 1–2 weeks to the is usually not on radiography the early of disease and can infection, diagnosing osteomyelitis at the the patient to the can be difficult on may help in cases are more sensitive for osteomyelitis the early of but are and can be The of various of but the of bone is generally MRI is the most useful of the MRI is the most for bone infection, and it also the most of deep soft-tissue infections. The of all these are with the of osteomyelitis, and are most useful for cases The for diagnosing osteomyelitis is of from a obtained of bone to with findings of and (B-II). few of the studies that have or have treatment have used MRI is usually not needed as a in cases of diabetic foot osteomyelitis is a obtaining often If these evidence of pathological findings in the patient should be for weeks for the soft-tissue If of osteomyelitis radiography 2–4 weeks If the of osteomyelitis and and and if there is of a for osteomyelitis, preferably after obtaining appropriate specimens for culture (B-III). If findings of radiography are only but not osteomyelitis, of the choices should be 1. MRI is the with preferably use or a If results of the are osteomyelitis is if results suggest osteomyelitis, consider bone is needed 2. antibiotic therapy for 2–4 weeks and to determine have suggest 3. an appropriate as defined of a of a or is if the remains in after or if osteomyelitis is likely but the etiologic or antibiotic are not also specimens of most or these are more difficult to and more often lead to a the an can the should preferably be or if possible. patients with may be of as by and and by have been specimens if at least for culture and for it may only be to a few of of foot bone and consider it to be a (B-II). of bone specimens more data those of soft-tissue specimens for patients with osteomyelitis medical and surgical have that a bone with chronic osteomyelitis for some have the for surgical Definitive surgical to osteomyelitis, as and may risk of the in and additional of and systemic of infection may make osteomyelitis for the who may for at medical management. these diabetic may also bone with or in infection, additional bone or soft-tissue and a These have some health care professionals to diabetic foot osteomyelitis with or surgical intervention on treatment with a of antibiotics have clinical in of cases these often to a of osteomyelitis, patients patients or and debridement of bone The of which patients are for as as duration of antibiotic therapy is needed, are important for there are cases in which of osteomyelitis be (B-II). 1. There is surgical of the infection cause of 2. The patient has ischemia by vascular disease but to 3. is to the and there is soft-tissue 4. The patient and health care that surgical risk or is not appropriate or therapy for osteomyelitis consider the is there necrotic or infected bone or surgical that should be or the selected antibiotic regimen likely the and adequate in and it for a sufficient the to bone infection the cause of the wound an usually in consultation with a patients may from antibiotics in or hyperbaric oxygen therapy, or may or antibiotic in some cases, an antibiotic The most appropriate duration of therapy for any type of diabetic foot infection has not been defined is important to consider the presence and of any or infected bone and the of the a infected tissue, antibiotic therapy is needed (B-II). if infected bone or despite treatment is osteomyelitis, some parenteral therapy may be especially if an with is used (C-III). therapy may be in the recommendations for duration of therapy are based on the clinical and are in 9. The of treating a diabetic foot infection are the of clinical evidence of infection and the of soft-tissue and a clinical response of clinical evidence of to appropriate therapy in of mild-to-moderate infections and in of severe infections or cases of osteomyelitis with a signs of systemic infection limb perfusion, osteomyelitis the presence of necrosis or gangrene an and of the infection in of especially in those with may be difficult to from a recent of of the Infections that the for treating diabetic foot osteomyelitis systematic of and patient treatment may be useful for and for multidisciplinary foot-care (B-II). patient who has foot infection is more likely to have a to with the patient of is the to prevent foot infections. the patient the of appropriate at all foot of the and any to health care professionals (A-II). can be in a few should these by patients foot care and their and Patients with severe substantial foot or ischemia should be to appropriate to with these (A-II). of the recommendations in are based on and adequately There are in which be particularly 1. a for infected foot lesions to studies of their and support to the for 2. there is a role for antibiotic therapy in managing clinically uninfected 3. optimal antibiotic regimens and for various of soft-tissue and bone infections. 4. a of osteomyelitis in the diabetic 5. and a for the and treatment of infections, especially 6. the of surgical and of of support or for and for for and and support from support or for and and for and support from and and for and of support from and for and and

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

The record

Venue

Clinical Infectious Diseases

Topic

Diabetic Foot Ulcer Assessment and Management

Field

Medicine

Canadian institutions

University of Manitoba

Funders

not available

Keywords

MedicineVeterans AffairsFamily medicinePodiatryGerontologyAlternative medicineInternal medicinePathology

Has abstract in OpenAlex

yes

API

/api/v1/works/W2084025044